References and Notes
<A NAME="RU06808ST-1A">1a</A>
Metzger JV.
Comprehensive
Heterocyclic Chemistry
Vol. 6:
Katritzky AR.
Rees CW.
Pergamon;
Oxford:
1984.
p.235-331
<A NAME="RU06808ST-1B">1b</A>
Dondoni A.
Merino P.
Comprehensive
Heterocyclic Chemistry II
Vol. 3:
Katritzky AR.
Rees CW.
Scriven EFV.
Elsevier
Science;
Oxford:
1996.
p.373-474
<A NAME="RU06808ST-1C">1c</A>
Boden CDJ.
Pattenden G.
Ye T.
Synlett
1995,
417
<A NAME="RU06808ST-1D">1d</A>
Wipf P.
Chem.
Rev.
1995,
95:
2115
<A NAME="RU06808ST-1E">1e</A>
Dondoni A.
Synthesis
1998,
1681
<A NAME="RU06808ST-1F">1f</A>
Potewar TM.
Ingale SA.
Srinivasan KV.
Tetrahedron
2007,
63:
11066
<A NAME="RU06808ST-1G">1g</A>
Yadav JS.
Reddy BVS.
Rao YG.
Narsaiah AV.
Tetrahedron Lett.
2008,
49:
2381
<A NAME="RU06808ST-1H">1h</A>
Potewar TM.
Ingale SA.
Srinivasan KV.
Tetrahedron
2008,
64:
5019
<A NAME="RU06808ST-2A">2a</A>
Haviv F.
Ratajczyk JD.
DeNet RW.
Kerdesky
FA.
Walters RL.
Schmidt SP.
Holms JH.
Young PR.
Carter GW.
J. Med. Chem.
1988,
31:
1719
<A NAME="RU06808ST-2B">2b</A>
Patt WC.
Hamilton HW.
Taylor MD.
Ryan MJ.
Taylor DG.
Connolly CJC.
Doherty AM.
Klutchko
SR.
Sircar I.
Steinbaugh BA.
Batley BL.
Painchaud
CA.
Rapundalo ST.
Michniewicz BM.
Olson SCJ.
J.
Med. Chem.
1992,
35:
2562
<A NAME="RU06808ST-2C">2c</A>
Tsuji K.
Ishikawa H.
Bioorg. Med. Chem. Lett.
1994,
4:
1601
<A NAME="RU06808ST-2D">2d</A>
Bell FW.
Cantrell AS.
Hoegberg M.
Jaskunas SR.
Johansson
NG.
Jordon CL.
Kinnick MD.
Lind P.
Morin JM.
Noreen R.
Oberg B.
Palkowitz JA.
Parrish CA.
Pranc P.
Sahlberg C.
Ternansky RJ.
Vasileff RT.
Vrang L.
West SJ.
Zhang H.
Zhou XX.
J. Med. Chem.
1995,
38:
4929
<A NAME="RU06808ST-3A">3a</A>
Hantzsch A.
Weber JH.
Ber.
Dtsch. Chem. Ges.
1887,
20:
3118
<A NAME="RU06808ST-3B">3b</A>
Wiley RH.
Behr LC.
Org.
Rec.
1951,
6:
367
<A NAME="RU06808ST-4A">4a</A>
Koser GF.
Wettach RH.
J. Org. Chem.
1977,
42:
1476
<A NAME="RU06808ST-4B">4b</A>
Moriarty RM.
Vaid RK.
Hopkins TE.
Vaid BK.
Prakash O.
Tetrahedron Lett.
1990,
31:
201
<A NAME="RU06808ST-4C">4c</A>
Moriarty RM.
Vaid RK.
Duncan MP.
Levy SG.
Prakash O.
Goyal S.
Synthesis
1992,
845
<A NAME="RU06808ST-4D">4d</A>
Prakash O.
Goyal S.
Synthesis
1992,
629
<A NAME="RU06808ST-4E">4e</A>
Prakash O.
Rani N.
Goyal S.
J.
Chem. Soc., Perkin Trans. 1
1992,
707
<A NAME="RU06808ST-4F">4f</A>
Prakash O.
Saini N.
Sharma PK.
Synlett
1994,
221
<A NAME="RU06808ST-4G">4g</A>
Ueno M.
Nabana T.
Togo H.
J.
Org. Chem.
2003,
68:
6424
<A NAME="RU06808ST-4H">4h</A>
Ueno M.
Togo H.
Synthesis
2004,
2673
<A NAME="RU06808ST-5">5</A>
Wipf P.
Venkatraman S.
J. Org. Chem.
1996,
61:
8004
<A NAME="RU06808ST-6A">6a</A>
Togo H.
Hoshina Y.
Muraki T.
Nakayama H.
Yokoyama M.
J. Org. Chem.
1998,
63:
5193
<A NAME="RU06808ST-6B">6b</A>
Katohgi M.
Togo H.
Yamaguchi K.
Yokoyama M.
Tetrahedron
1999,
55:
14885
<A NAME="RU06808ST-6C">6c</A>
Harada Y.
Togo H.
Yokoyama M.
J. Org. Chem.
2000,
65:
926
<A NAME="RU06808ST-6D">6d</A>
Misu Y.
Togo H.
Org. Biomol. Chem.
2003,
1:
1342
<A NAME="RU06808ST-6E">6e</A>
Akiike J.
Yamamoto Y.
Togo H.
Synlett
2007,
2168
<A NAME="RU06808ST-6F">6f</A>
Kawano Y.
Togo H.
Synlett
2008,
217
<A NAME="RU06808ST-7">7</A>
Koser GF.
Sun G.
Porter CW.
Youngs WJ.
J. Org. Chem.
1993,
58:
7310
<A NAME="RU06808ST-8">8</A>
Typical Procedure
for Preparation of 1
H
-1-(1′-Hexynyl)-5-methyl-1,2,3-benziodoxathiole
3,3-Dioxide
A mixture of 1H-1-hydroxy-5-methyl-1,2,3-benziodoxa-thiole
3,3-dioxide (5 mmol), PTSA˙H2O
(5 mmol), and 1-hexyne (25 mmol) in MeCN (40 mL) was refluxed for
20 h. After removal of the solvent to obtain an oil, a solution
of the oil in CHCl3 (200 mL) was washed with 5% NaHCO3 (80 mL)
and H2O (3 × 50 mL), and was
concentrated to a solid. Recrystallization of the solid with a mixture
of CH2Cl2 (30 mL), Et2O (100 mL),
and hexane (60 mL) gave 1H-1-(1′-hexynyl)-5-methyl-1,2,3-benziodoxathiole
3,3-dioxide in 53% yield.
1
H
-1-(1′-Hexynyl)-5-methyl-1,2,3-benziodoxathiole
3,3-Dioxide (R =
n
-Bu)
Mp
164-166 ˚C (dec.); lit.7 179-181 ˚C
(dec.). IR (Nujol): 2166 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 8.01(s,
1 H), 7.92 (d, J = 8.5
Hz, 1 H), 7.47 (d, J = 8.7
Hz, 1 H), 2.73 (t, J = 7.2
Hz, 2 H), 2.50 (s, 3 H), 1.61-1.74 (m, 2 H), 1.43-1.55
(m, 2 H), 0.98 (t, J = 7.4
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 143.7, 141.6, 135.1,
130.8, 126.8, 115.5, 105.8, 29.9, 28.5, 22.1, 20.8, 20.6, 13.5.
1
H
-1-(1′-Octynyl)-5-methyl-1,2,3-benziodoxathiole
3,3-Dioxide (R =
n
-C
6
H
13
)
Mp
150 ˚C (dec.); lit.7 152-154 ˚C
(dec.). IR (Nujol): 2168 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 8.04
(s, 1 H), 7.90 (d, J = 8.7
Hz, 1 H), 7.48 (dd, J = 1.6,
8.6 Hz, 1 H), 2.73 (t, J = 7.1
Hz, 2 H), 2.51 (s, 3 H), 1.64-1.74 (m, 2 H), 1.42-1.52
(m, 2 H), 1.30-1.40 (m, 4 H), 0.92 (t, J = 7.0
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 143.8, 141.5, 135.0, 130.8,
126.6, 115.5, 105.8, 31.1, 28.5, 28.4, 27.8, 22.4, 20.9, 20.7, 14.0.
1
H
-1-(1′-Phenylethynyl)-5-methyl-1,2,3-benziodoxa-thiole
3,3-Dioxide (R = Ph)
Mp
217-219 ˚C (dec.); lit.7 221-223 ˚C
(dec.). IR (Nujol): 2160 cm-¹. ¹H
NMR (400 MHz, DMSO-d
6, TMS): δ = 8.12 (d, J = 8.4, 1
H), 7.76-7.81(m, 3 H), 7.53-7.67 (m, 4 H), 2.45
(s, 3 H). ¹³C NMR (100 MHz, DMSO-d
6, TMS): δ = 142.6,
142.4, 135.0, 133.0, 131.6, 129.1, 129.1, 128.9, 119.4, 107.7, 107.2,
41.3, 20.2.
Typical Procedure for Preparation
of Thiazoles
To a solution of thiobenzamide (0.48
mmol) in THF (2 mL) were added K2CO3 (0.92
mmol) and 1H-1-(1′-phenyl-ethynyl)-5-methyl-1,2,3-benziodoxathiole
3,3-dioxide (0.4 mmol). The obtained mixture was stirred at 45 ˚C
overnight under argon atmosphere. After the reaction, the mixture
was filtered to remove potassium 2-iodo-5-methyl-benzene-sulfonate
quantitatively. After evaporation of the filtrate, the residue was
chromatographed on SiO2 (eluent: hexane-CHCl3,
1:1) to afford pure 1,4-diphenylthiazole in 65% yield.
2,4-Diphenylthiazole
Mp 91-92 ˚C;
lit.¹0 91-92 ˚C. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 7.98-8.09
(m, 4 H), 7.41-7.51 (m, 6 H), 7.35 (t, J = 7.4
Hz, 1 H).
Regeneration of Potassium
2-Iodo-5-methylbenzene-sulfonate to 1
H
-1-Hydroxy-5-methyl-1,2,3-benziod-oxathiole
3,3-Dioxide
Hydrogen peroxide (33%, 1.3 mL)
was added dropwise to a solution of acetic anhydride (1.2 mL) at
0 ˚C. The obtained mixture was stirred overnight. After
the reaction, the mixture was added dropwise to a stirred mixture
of potassium
2-iodo-5-methylbenzenesulfonate (2.4 mmol)
in AcOH (4 mL) and concd H2SO4 (1.2 mL) while
keeping the temperature at 10-15 ˚C. The mixture
was stirred at this temperature for 1 h and overnight at r.t. After
the reaction, the precipitate was filtered to give 1H-1-hydroxy-5-methyl-1,2,3-benziodoxathiole
3,3-dioxide in 50-60% yield.
2-Phenyl-4-butylthiazole
Oil.
IR(neat): 2956, 2929, 2859, 1516, 1498, 1460, 1436, 1244, 1004,
763, 689 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 7.93
(dd, J = 1.4,
8.0 Hz, 2 H), 7.38-7.45 (m, 3 H), 6.86 (s, 1 H), 2.83 (t, J = 7.8 Hz,
2 H), 1.70-1.80 (m, 2 H), 1.37-1.49 (m, 2 H),
0.96 (t, J = 7.4
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 167.4, 158.9, 133.9,
129.7, 128.8, 126.5, 112.6, 31.4, 31.3, 22.4, 13.9. HRMS-FAB:
m/z calcd for C13H16NS [M + H]:
218.1003; found: 218.1006.
2-Methyl-4-butylthiazole
Oil.
IR(neat): 3427, 2956, 2929, 2859, 1637, 1523, 1457, 1183, 1133,
730, 560, 526 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 6.69
(s, 1 H), 2.67-2.76 (m, 5 H), 1.62-1.73 (m, 2
H), 1.32-1.44 (m, 2 H), 0.93 (t, J = 7.4
Hz, 3 H).¹³C NMR (100 MHz, CDCl3,
TMS): δ = 165.2, 157.3, 111.9,
31.4, 31.2, 22.4, 19.1, 13.9. HRMS-FAB: m/z calcd
for C8H14NS [M + H]:
156.0847; found: 156.0837.
2-(4-Methylphenyl)-4-butylthiazole
Oil.
IR(neat): 2955, 2928, 2859, 1509, 1457, 1246, 1007, 818, 735, 711
cm-¹. ¹H NMR (400
MHz, CDCl3, TMS): δ = 7.82
(d, J = 8.2
Hz, 2 H), 7.22 (d, J = 8.0
Hz, 2 H), 6.82 (s, 1 H), 2.81 (t, J = 7.7
Hz, 2 H), 2.38 (s, 3 H), 1.69-1.79 (m, 2 H), 1.36-1.48
(m, 2 H), 0.96 (t, J = 7.4
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 167.6, 158.7, 139.8,
131.3, 129.5, 126.4, 112.1, 31.4, 31.3, 22.4, 21.4, 13.9. HRMS-FAB: m/z calcd for C14H18NS [M + H]:
232.1160; found: 232.1161.
2-(4-Methoxyphenyl)-4-butylthiazole
Oil.
IR(neat): 2859 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 7.87
(d, J = 8.9
Hz, 2 H), 6.94 (d, J = 9.0
Hz, 2 H), 6.79 (s, 1 H), 3.85 (s, 3 H), 2.81 (t, J = 7.7
Hz, 2 H), 1.68-1.80 (m, 2 H), 1.36-1.48 (m, 2
H), 0.96 (t, J = 7.3
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 167.5, 161.0, 158.7,
128.1, 127.1, 114.3, 111.8, 55.5, 31.6, 31.5, 22.6, 14.1. HRMS-FAB: m/z calcd for C14H18NOS [M + H]: 248.1109;
found: 248.1119.
2-(4-Nitrophenyl)-4-butylthiazole
Mp
47-48 ˚C. IR (Nujol): 1522, 1345, 851 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 8.29
(d, J = 8.9
Hz, 2 H), 8.11 (d, J = 9.2
Hz, 2 H), 7.03 (s, 1 H), 2.85 (t, J = 7.7
Hz, 2 H), 1.71-1.81 (m, 2 H), 1.38-1.49 (m, 2
H), 0.97 (t, J = 7.4
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 164.2, 160.1, 148.2,
139.4, 127.0, 124.2, 115.0, 31.3, 22.3, 13.9. HRMS-FAB: m/z calcd for C13H15N2O2S [M + H]:
263.0854; found: 263.0838.
2-Amino-4-butylthiazole
Oil.
IR (Nujol): 3436, 1607, 1521, 1113, 696 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 6.08
(s, 1 H), 4.91 (s, 2 H), 2.53 (t, J = 7.8
Hz, 2 H), 1.56-1.68 (m, 2 H), 1.30-1.43 (m, 2
H), 0.92 (t, J = 7.4
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3, TMS): δ = 167.3,
102.5, 102.5, 31.7, 31.2, 22.7, 14.2. HRMS-FAB: m/z calcd for C7H13N2S [M + H]:
157.0799; found: 157.0811.
2-Phenyl-4-hexylthiazole
Oil.
IR(neat): 2926, 2856, 1517, 1458, 1239, 1003, 763, 689 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 7.94
(dd, J = 1.7,
7.8 Hz, 2 H), 7.36-7.47 (m, 3 H), 6.87 (s, 1 H), 1.70-1.82
(m, 2 H), 1.27-1.47 (m, 6 H), 0.89 (t, J = 7.1
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 167.4, 158.9, 133.9, 129.7,
128.8, 126.5, 112.6, 31.7, 31.7, 29.2, 29.0, 22.6, 14.1. HRMS-FAB: m/z calcd for C15H20NS [M + H]:
246.1316; found: 246.1315.
2-Methyl-4-hexylthiazole
Oil.
IR(neat): 2955, 2926, 2856, 1523, 1457, 1183, 728 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 6.69
(s, 1 H), 2.67-2.75 (m, 5 H), 1.62-1.75 (m, 2
H), 1.23-1.45 (m, 6 H), 0.88 (t, J = 7.0
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 165.2, 157.4, 111.9,
31.6, 31.6, 29.2, 29.0, 22.6, 19.1, 14.1. HRMS-FAB: m/z calcd for C10H18NS [M + H]: 184.1160;
found: 184.1167.
2-(4-Methylphenyl)-4-hexylthiazole
Oil.
IR(neat): 2926, 2856, 1509, 1457, 1247, 1005, 817, 711 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 7.82
(d, J = 8.3
Hz, 2 H), 7.22 (d, J = 7.8
Hz, 2 H), 6.82 (s, 1 H), 2.80 (t, J = 7.6
Hz, 2 H), 2.38 (s, 3 H), 1.70-1.81 (m, 2 H), 1.27-1.46
(m, 6 H), 0.89 (t, J = 7.1
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 167.6, 158.7, 139.9,
131.3, 129.5, 126.4, 112.1, 31.7, 31.7, 29.2, 29.0, 22.6, 21.4,
14.1. HRMS-FAB: m/z calcd
for C16H22NS [M + H]:
260.1473; found: 260.1493.
2-(4-Methoxyphenyl)-4-hexylthiazole
Oil.
IR(neat): 2855 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 7.87
(d, J = 9.0
Hz, 2 H), 6.94 (d, J = 8.8
Hz, 2 H), 6.79 (s, 1 H), 3.85 (s, 3 H), 2.80 (t, J = 7.8
Hz, 2 H), 1.69-1.80 (m, 2 H), 1.25-1.45 (m, 6
H), 0.89 (t, J = 6.9
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 160.8, 158.6, 134.0,
127.9, 126.9, 114.1, 111.7, 55.4, 31.7, 31.7, 29.2, 29.0, 22.6,
14.1. HRMS-FAB: m/z calcd
for C16H22NOS [M + H]:
276.1422; found: 276.1401.
2-(4-Nitrophenyl)-4-hexylthiazole
Mp
45-46 ˚C. IR (Nujol): 1523, 1339, 852 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 8.28
(d, J = 8.8
Hz, 2 H), 8.10 (d, J = 9.1
Hz, 2 H), 7.03 (s, 1 H), 2.84 (t, J = 7.8
Hz, 2 H), 1.72-1.81 (m, 2 H), 1.30-1.45 (m, 6
H), 0.90 (t, J = 7.8
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 164.2, 160.1, 148.2,
139.4, 127.0, 124.2, 115.0, 31.6, 31.6, 29.1, 28.9, 22.6, 14.1.
HRMS-FAB: m/z calcd
for C15H19N2O2S [M + H]:
291.1167; found: 291.1169.
2-Amino-4-hexylthiazole
Mp
45-46 ˚C. IR (Nujol): 3432, 3235, 1606, 1508,
1103, 706 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 6.08
(s, 1 H), 4.92 (s, 2 H), 2.52 (t, J = 6.9
Hz, 2 H), 1.56-1.68 (m, 2 H), 1.24-1.39 (m, 6
H), 0.88 (t, J = 6.9
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 167.0, 153.7, 102.2,
31.7, 31.6, 29.0, 28.7, 22.6, 14.1. HRMS-FAB: m/z calcd for C9H17N2S [M + H]:
185.1112; found: 185.1106.
2-Phenyl-4-butylthiazole
Oil.
IR(neat): 2956, 2929, 2859, 1516, 1498, 1460, 1436, 1244, 1004,
763, 689 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 7.93
(dd, J = 1.4,
8.0 Hz, 2 H), 7.38-7.45 (m, 3 H), 6.86 (s, 1 H).
2-Methyl-4-phenylthiazole
Mp 60 ˚C;
lit.4h 64 ˚C. ¹H NMR (400
MHz, CDCl3, TMS): δ = 7.87
(d, J = 8.3
Hz, 2 H), 7.41 (t, J = 7.5
Hz, 2 H), 7.32 (t, J = 7.5
Hz, 1 H), 7.31 (s, 1 H), 2.78 (s, 3 H).
2-(4-Methylphenyl)-4-phenylthiazole
Mp
126 ˚C. IR (Nujol): 974, 815, 741, 690, 676 cm-¹. ¹H NMR
(400 MHz, CDCl3, TMS): δ = 8.00
(d, J = 8.2
Hz, 2 H), 7.94 (d, J = 8.2
Hz, 2 H), 7.41-7.48 (m, 3 H), 7.35 (t, J = 7.3
Hz, 1 H), 7.26 (d, J = 6.5
Hz, 2 H), 2.41 (s, 3 H). ¹³C NMR (100
MHz, CDCl3, TMS): δ = 168.0,
156.1, 140.3, 134.6, 131.1, 129.6, 128.7, 128.1, 126.5, 126.4, 112.1,
21.4. HRMS-FAB: m/z calcd
for C16H14NS [M + H]:
252.0847; found: 252.0851.
2-(4-Methoxyphenyl)-4-phenylthiazole
Mp
97-98 ˚C. IR (Nujol): 1256, 1173, 979, 833, 738
cm-¹. ¹H NMR (400
MHz, CDCl3, TMS): δ = 7.96-8.02
(m, 4 H), 7.40-7.48 (m, 3 H), 7.34 (t, J = 7.4
Hz, 1 H), 6.98 (d, J = 8.9 Hz,
2 H), 3.88 (s, 3 H). ¹³C NMR (100 MHz,
CDCl3, TMS): δ = 177.6,
161.4, 134.9, 133.6, 128.9, 128.3, 127.0, 126.6, 115.0, 114.5, 111.9,
55.7. HRMS-FAB: m/z calcd
for C16H14NOS [M + H]:
268.0796; found: 268.0802.
2-(4-Nitrophenyl)-4-phenylthiazole
Mp
164-165 ˚C. IR (Nujol): 1514, 1339, 849 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 8.33
(d, J = 8.9
Hz, 2 H), 8.22 (d, J = 8.9
Hz, 2 H), 8.00 (d, J = 8.2
Hz, 2 H), 7.63 (s, 1 H), 7.48 (t, J = 7.4
Hz, 2 H), 7.40 (t, J = 7.4
Hz, 1 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 164.8, 157.3, 148.4,
139.1, 133.9, 128.9, 128.7, 127.1, 126.5, 124.3, 114.6. HRMS-FAB: m/z calcd for C15H11N2O2S [M + H]:
283.0541; found: 283.0547.
2-Amino-4-phenylthiazole
Mp
145-147 ˚C. IR (Nujol): 3433, 1595, 1518, 1038,
714 cm-¹. ¹H NMR
(400 MHz, CDCl3, TMS): δ = 7.78
(d, J = 8.0
Hz, 2 H), 7.38 (t, J = 7.6
Hz, 2 H), 7.29 (t, J = 7.4
Hz, 1 H), 6.73 (s, 1 H), 5.03 (s, 2 H). ¹³C
NMR (100 MHz, CDCl3, TMS): δ = 167.0,
151.3, 134.6, 128.6, 127.7, 126.0, 102.9. HRMS-FAB: m/z calcd for C9H9N2S [M + H]: 177.0486;
found: 177.0485.
<A NAME="RU06808ST-9">9</A>
Singh CB.
Ghosh H.
Murru S.
Patel BK.
J. Org. Chem.
2008,
73:
2924
<A NAME="RU06808ST-10">10</A>
Ishida M.
Nakanishi H.
Kato S.
Chem.
Lett.
1984,
1691